The Alberta Diet: Effectiveness Study

December 9, 2016 updated by: University of Alberta

The Alberta Diet: a Proposal for Its Implementation

The study hypothesis is that individuals with type 2 diabetes (T2D), who adhere to the PANDA intervention, will have improved compliance with the nutritional therapy recommendations of the Canadian Diabetes Association. Specific objectives of this proposal: The objectives of the investigators PANDA (Physical Activity and Nutrition for Diabetes in Alberta) are to (a) to devise and evaluate the efficacy of a multi-level, practical, nutrition intervention program that promotes the individual factors required for effective self-management practices AND that explicitly incorporate strategies to improve food availability, accessibility and acceptability and (b) to use these interventions as a means to examine the relationships between food availability, accessibility, acceptability, adherence to Nutrition Therapy Guidelines, and metabolic indicators of diabetes control in people with type 2 diabetes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

73

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alberta
      • Edmonton, Alberta, Canada, T6G 2R3
        • Alberta Diabetes Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Type 2 diabetes, and speak/write English.
  • Have attended a diabetes education session delivered by their healthcare provider.

Exclusion Criteria:

  • Participants with type 1 diabetes, and those who are unable to speak English.
  • People with end-stage renal disease or gastrointestinal diseases that require specialized diets will also be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PANDA intervention
12 week nutritional intervention, including 6 classroom/community sessions, plus two sample collection visits.
Participants will follow a menu plan and receive training in how to manage their diet in type 2 diabetes, following the recommendations of the Canadian Diabetes Association, 2008

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Total Energy Intake
Time Frame: 4 months
Measured using repeated 24 hour dietary recalls (pre and post-intervention)
4 months
Change in Macronutrient Intake
Time Frame: 3 months
Measured using repeated 24 hour dietary recalls (pre and post-intervention)
3 months
Change in Nutrient Intake
Time Frame: 3 months
Measured using repeated 24 hour dietary recalls (pre and post-intervention)
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Hemoglobin A1c
Time Frame: 4 months
a surrogate of blood glucose control
4 months
Program Retention
Time Frame: 3 months
attendance at meetings
3 months
Change in Body Mass Index
Time Frame: 4 months
Actual weight and height used to calculate BMI pre- and post-intervention
4 months
Body Composition
Time Frame: 3 months
body fat and fat-free mass
3 months
Change in Blood Biomarkers
Time Frame: 4 months
blood lipids: triglyceride, total cholesterol, LDL-cholesterol, HDL-cholesterol
4 months
Change in Perceived Dietary Adherence Questionnaire Score
Time Frame: 4 months
Questionnaire assessing self-reported adherence to 9 criteria, whose individual scores (range 0-7) are summed to get the total score. Maximum total score is 63. Minimum total score is 0. A higher score means higher dietary adherence.
4 months
Food Acceptability
Time Frame: 4 months
questionnaire based on items related to personal and cultural acceptability of the recommended diet
4 months
Food Accessibility
Time Frame: 4 months
questionnaire of items related to financial and physical accessibility of foods in the diet recommended for diabetes
4 months
Food Availability
Time Frame: 4 months
questionnaire of items related to the availability in local stores of the food items recommended in the diet for diabetes.
4 months
Change in Waist Circumference
Time Frame: 4 months
Measured using repeated 24 hour dietary recalls (pre and post-intervention
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Catherine B Chan, PhD, University of Alberta

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (Actual)

October 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

June 19, 2012

First Submitted That Met QC Criteria

June 20, 2012

First Posted (Estimate)

June 21, 2012

Study Record Updates

Last Update Posted (Estimate)

February 6, 2017

Last Update Submitted That Met QC Criteria

December 9, 2016

Last Verified

December 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • RES0013109

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes

Clinical Trials on PANDA intervention

Subscribe